ESCRS FLACS study update: More postop complications with femto than phaco

BARCELONA — The updated European Society of Cataract and Refractive Surgeons study on femtosecond laser-assisted cataract surgery finds that “femto does not outperform phaco,” according to Peter Barry, MD, who delivered this year’s results.Although the ESCRS FLACS study found the femtosecond procedure to result in significantly better outcomes in terms of postoperative and surgically induced astigmatism, postoperative complications outnumbered those of phaco surgery, leading to a significantly higher percentage of patients with worse visual acuity than before surgery, Barry said at the ESCRS meeting.

First Patient Enrolled in Ocata Therapeutics’ Phase 2 Study for Dry AMD

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that the first patient has been enrolled in the company’s Phase 2 clinical trial using Ocata’s proprietary RPE cells in patients with atrophic (dry) age-related macular degeneration (AMD). The purpose of the trial is to evaluate safety and explore efficacy as compared to a parallel control group. Interim top-line results from the first cohort is expe